LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Hospital Clínico San Carlos de Madrid
Madrid, EspañaHospital Clínico San Carlos de Madrid -ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2023
-
Virtual coach and telerehabilitation for Parkinson´s disease patients: vCare system
Journal of Public Health (Germany)
2021
-
Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1
Neurologia, Vol. 36, Núm. 2, pp. 149-158
-
Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2
Neurologia, Vol. 36, Núm. 2, pp. 159-168
2019
-
Clinical and genetic characteristics of late-onset Huntington's disease
Parkinsonism and Related Disorders, Vol. 61, pp. 101-105
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
One-year clinical experience of perampanel in Spain: A multicentre study of efficacy and tolerability
Epileptic Disorders, Vol. 18, Núm. 2, pp. 173-180
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218
-
levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades
Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688